CLINICAL_TRIALS
trial_result
· 2021-04-19
Clinical Trial Update: Effects of Empagliflozin on Left Ventricular Diastolic Function Compared to Usual Care in Type 2 Diabetics [Phase 4]
Summary
A Phase 4 trial assessing the effects of empagliflozin on left ventricular diastolic function in adults with type 2 diabetes and diastolic dysfunction; study co…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Johannes Gutenberg University Mainz | Conditions: Diabetes Mellitus, Type 2, Diastolic Dysfunction | Phase 4 | Status: COMPLETED